Would you consider a distal esophageal adenocarcinoma as a GEJ cancer to be able to use immune check point inhibitor therapy?  

Since immune check point inhibitors have been approved for GEJ and gastric cancer, would a distal esophogeal adenocarcinoma be considered GEJ or does part of the cancer have to extend into the stomach?